Cell‐cycle risk score more accurately determines the risk for metastases and death in prostatectomy patients compared with clinical features alone

BACKGROUND: Prostate cancer treatment aims to prevent metastases and disease‐specific mortality. Pathologic parameters have limited ability to predict these outcomes, but biomarkers can improve risk discrimination. We evaluated the ability of cell‐cycle progression and combined cell‐cycle risk score...

Descripción completa

Detalles Bibliográficos
Autores principales: Swanson, Gregory P., Lenz, Lauren, Stone, Steven, Cohen, Todd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898933/
https://www.ncbi.nlm.nih.gov/pubmed/33475174
http://dx.doi.org/10.1002/pros.24103

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898933/
https://www.ncbi.nlm.nih.gov/pubmed/33475174
http://dx.doi.org/10.1002/pros.24103

Ejemplares similares